GSK to close German vaccine plant impacting 641 jobs
GlaxoSmithKline plans to shut down its Dresden vaccine facility by the summer of 2027. The closure places 641 jobs at risk as the company consolidates operations at a Canadian site amid declining demand for egg-based flu vaccines.
Xurve View
Insights:
Xurve View

